Sign Up Today and Learn More About HyperStealth Biotechnology Stock
Invest in or calculate the value of your shares in HyperStealth Biotechnology or other pre-IPO companies through EquityZen's platform.
HyperStealth Biotechnology Stock (HYSB)
HyperStealth Biotechnology develops military camouflage technology used in uniforms, vehicles, hunting tools, and stealth activities.
About HyperStealth Biotechnology Stock
Founded
1999
Total Funding
20K
Industries
Science and Engineering, Health Care, Food and Beverage
HyperStealth developed the world’s first Passive Negative Ion Generator Patent#: CA 2,282,155 International Patent Classification (IPC) H01T 23/00. The "Passive Negative Ion Generator" is currently being used by a number of Special Forces Teams which have been adapted to their combat gear for performance enhancement without the side effects often associated with drugs or dietary supplements often required for duty and training. In 2002 Guy Cramer, President/CEO of HyperStealth and the inventor of the Passive Negative Ion Generator, began to develop new military camouflage based on mathematical fractals (feedback loops) taking camouflage into an area of science that had been proposed by the experts but none were able to design.
Join now and verify your accreditation status to gain access to:
- HyperStealth Biotechnology Current Valuation
- HyperStealth Biotechnology Stock Price
- HyperStealth Biotechnology Management
- Available deals in HyperStealth Biotechnology and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- HyperStealth Biotechnology Cap Table and Funding History by Share Class and Liquidity Preferences
- HyperStealth Biotechnology Revenue and Financials
- HyperStealth Biotechnology Highlights
- HyperStealth Biotechnology Business Model
- HyperStealth Biotechnology Risk Factors
- HyperStealth Biotechnology Research Report from SACRA Research
Trading HyperStealth Biotechnology Stock
How to invest in HyperStealth Biotechnology stock?
Accredited investors can buy pre-IPO stock in companies like HyperStealth Biotechnology through EquityZen funds. These investments are made available by existing HyperStealth Biotechnology shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell HyperStealth Biotechnology stock?
Shareholders can sell their HyperStealth Biotechnology stock through EquityZen's private company marketplace. EquityZen's network includes over 350K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 45K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
